Clinical Trials Directory

Trials / Completed

CompletedNCT03138135

HOME Study: a Combination Support Package to Increase Uptake of PrEP and HIV/STI Testing

HOME Study: Evaluation of a Combination Support Package to Increase Uptake of Pre-exposure Prophylaxis and HIV/STI Testing Among Young Black and Latino MSM in the San Francisco Bay Area.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
104 (actual)
Sponsor
Public Health Foundation Enterprises, Inc. · Academic / Other
Sex
Male
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Home HIV self-testing has been FDA approved and allows users to read their own HIV test results at home, while home sexually transmitted infection (STI) test self-collection allows men to use a swab at home and mail it in for testing. The purpose of this study is to learn how Men who have Sex with Men (MSM) use these new testing options, a set of online support tools, and the option to test with someone to support them (a testing "buddy"). We will also evaluate whether the online tools help these men to connect with HIV prevention services such as Pre-Exposure Prophylaxis (PrEP) if they test HIV negative, and to HIV care services if they test HIV positive.

Detailed description

Participants will be randomized 2:1 after enrollment to the intervention and control condition. Data obtained from this study will be used to inform the further tailoring and distribution of an intervention for young Black and Latino MSM to increase utilization of home HIV self-testing and linkage to HIV treatment and Pre-Exposure Prophylaxis (PrEP).

Conditions

Interventions

TypeNameDescription
BEHAVIORALHOME Study interventionAccess to home HIV test kits, home STI self-collection kits, the HOME Study website, and the SexPro HIV risk assessment tool.
BEHAVIORALControlCounseling about the importance of quarterly HIV/STI testing and a PrEP information pamphlet.

Timeline

Start date
2017-01-09
Primary completion
2018-11-30
Completion
2018-11-30
First posted
2017-05-03
Last updated
2021-04-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03138135. Inclusion in this directory is not an endorsement.